Conventional lung cancer treatment protocols often call for radiation therapy to be administered after chemotherapy for patients with locally advanced non–small cell lung cancer (NSCLC). However, a new treatment standard may be on the horizon.
Women with the BRCA gene mutation are diagnosed with breast cancer approximately 8 years earlier than relatives of the previous generation who also had breast and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.
The findings, published online in Cancer, could have an effect on how women with the highest breast cancer risk are counseled and even screened in the future, explained Jennifer Litton, MD, assistant professor in MD Anderson’s Department of Breast Medical Oncology.
The largest population of cancer survivors in the United States are those who have defeated breast cancer. Often times survivors attempt to return to the workplace after treatment, but symptoms and long-term side effects can influence their ability to work. However, a recent development can help address these issues.
Dual backup circuits in cancer cells that allow the cells to evade the effects of a common cancer drug have been discovered by scientists at Dana-Farber Cancer Institute and colleagues in Japan. Using targeted therapies to disconnect those circuits may improve or re-establish the cancer drug’s effectiveness, according to a study published in the September 7 issue of Science Translational Medicine.
Simulation-based training is an effective technique for teaching physicians, nurses, dentists, emergency medical technicians, and other health professionals, according to a research review led by Mayo Clinic researchers. More than 600 studies assessing the use of virtual reality computers, mannequins, and training models used for teaching skills related to surgery, trauma management, obstetrics, and team communication were analyzed. Conclusions from the review were published September 7 in the Journal of the American Medical Association.
High doses of chemotherapy may cause expressive speech difficulties in cancer patients, according to new research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
After standard neoadjuvant chemotherapy, nearly half of breast cancer patients carrying the BRCA1 gene mutation achieve a complete pathological response (pCR) despite the stage of their disease, according to new research from The University of Texas MD Anderson Cancer Center recently published online in the Journal of Clinical Oncology.
A new lifesaving genetic screening program has been developed by UT Southwestern Medical Center for families at high risk of contracting colorectal cancer, the second-leading cancer killer after lung cancer, according to the American Cancer Society.
The amount of potential carcinogens attached to an individual’s DNA can be measured by a new saliva test. This could lead to a commercial test to help determine risks for cancer and other diseases, scientists reported during the 242nd National Meeting & Exposition of the American Chemical Society.
To sign up for our newsletter or print publications, please enter your contact information below.